Presumed Traumatic Central Serous Chorioretinopathy: A Case Report

Article Sidebar

PDF
Published Aug 29, 2025
DOI: https://doi.org/10.18103/mra.v13i8.6829

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Meghan Gorniak, MS
SSMHealth Medical Group, Department of Ophthalmology, Saint Louis University, School of Medicine, St. Louis, MO
Anahita Dadali, MBBS iBSc (Hons)
St. George’s, University of London, London, England
Sweta Kavali, MD
Ophthalmology Consultants, St. Louis, MO
Niloofar Piri, MD
SSMHealth Medical Group, Department of Ophthalmology, Saint Louis University, School of Medicine, St. Louis, MO

Abstract

Background: Central serous chorioretinopathy describes central neurosensory detachment of the retina due to the accumulation of subretinal fluid.  Both pathophysiology and proposed etiology/risk factors of the condition have been reported. However, an association between blunt trauma to the eye and central serous chorioretinopathy has not been established.


Objective: To report a unique case of central serous chorioretinopathy development following trauma to the affected eye.


Method: Case report. Diagnosis was confirmed with a comprehensive ocular exam and imaging.


Results: A 42-year-old Caucasian male presented with sudden blurry vision in the left eye one day after being hit with a Nerf gun dart. He denied any risk factors of central serous chorioretinopathy including increased stress, corticosteroid use, or underlying autoimmune disease. Visual acuity was 20/80 in the left eye. Posterior segment examination revealed circumscribed subretinal fluid 4-disc diameter in size involving the fovea.  Findings were supported by spectral domain optical coherence tomography showing large neurosensory detachment and fundus autofluorescence demonstrated well defined hyperautofluorescence corresponding to the detached area.  Fluorescein angiography revealed an expansile dot pattern, confirming the diagnosis of central serous chorioretinopathy.  Patient returned five weeks later with improved vision and significantly improved subretinal fluid with conservative management.


Conclusion: This case report of central serous chorioretinopathy development with a presumed traumatic etiology is only the fourth reported case with no available cohort studies. Thus far, conservative management remains the primary treatment method; yet treatment courses following trauma have been largely understudied to limited case numbers. Additionally, further research is necessary to better distinguish individual risk factors compared to trauma-related risk factors.

Article Details

How to Cite
GORNIAK, Meghan et al. Presumed Traumatic Central Serous Chorioretinopathy: A Case Report. Medical Research Archives, [S.l.], v. 13, n. 8, aug. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6829>. Date accessed: 05 dec. 2025. doi: https://doi.org/10.18103/mra.v13i8.6829.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 13 No 8 (2025): Vol.13, Issue 8, August 2025
Section
Case Reports

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Zhang, X., Lim, C. et al (2023). Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies, BMC, 10: pp. 33.
2. Wang, M., Munch, I. et al (2008) Central serous chorioretinopathy, Acta Ophthalmologica, 86: pp. 126-145.
3. Liew, G., Quin, G., et al (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology, Clinical and Experimental Ophthalmology, 41: pp. 201-214.
4. Gäckle, H., Lang G., et al (1998) Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects, Ophthalmole, 95: pp. 529-533.
5. Spaide, R., Campeas, L., et al (1996) Central Serous Chorioretinopathy in younger and older adults, Ophthalmology, 103: pp. 2070-2080.
6. Giovannini, A., Scassellati-Sforzolini, B., et al (1997) Choroidal Findings in the Course of Idiopathic Serous Pigment Epithelium Detachment by Indocyanine Green Videoangiography, Retina, 17: pp. 286-296.
7. Cheung, C., Lee, W., Koizumi, H., et al (2019) Pachychoroid disease. Eye (London), 33: pp. 14–33.
8. Zarnegar, A., Ong, J., Matsyaraja, T., et al (2023) Pathomechanisms in central serous chorioretinopathy: A recent update, International Journal of Retinal and Vitreous, 9: pp. 3.
9. Gass, J. (1967) Pathogenesis of disciform detachment of the neuroepithelium. American Journal of Ophthalmology, 63: pp.1–139.
10. Wang, Z., Xin, Z. and Yang, J. (2021) Choriocapillaris ischemia at the leakage point of patients with acute central serous chorioretinopathy. Front Med (Lausanne), 8: pp. 675876.
11. Lim, J., Kim, M. and Shin, M. (2010) Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy. Retina, 30: pp. 1465–1471.
12. Prünte, C. and Flammer, J. (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. American Journal of Ophthalmology, 121: pp. 26–34.
13. Spaide, R., Gemmy Cheung, C., Matsumoto, H., et al (2021) Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res, 86: pp. 100973.
14. Lejoyeux, R., Benillouche, J., Ong, J., et al (2022) Choriocapillaris: fundamentals and advancements. Prog Retin Eye Res, 87: pp. 100997.
15. Pang, C., Shah, V., Sarraf, D., Freund, K. (2014) Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy. American Journal of Ophthalmology, 158: pp. 362–371.
16. Brinks, J., van Dijk E., Meijer, O., et al (2022) Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities. Acta Ophthalmology, 100: pp. 946-959.
17. Terao, N., Imanaga, N., Wakugawa, S., et al (2021). Short axial length is related to asymmetric vortex veins in central serous chorioretinopathy. Ophthalmology Scientific, 1: pp. 100071.
18. Bacci, T., Oh, D., Singer, M., et al (2022) Ultra-widefield indocyanine green angiography reveals patterns of choroidal venous insufficiency influencing pachychoroid disease. Invest Ophthalmol Vis Sci, 63: pp. 17.
19. Mori, K., Gehlbach, P., Yoneya, S., Shimizu, K. (2004) Asymmetry of choroidal venous vascular patterns in the human eye. Ophthalmology, 111: pp. 507–512.
20. Hiroe, T., Kishi, S. (2018) Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retina, 2: pp. 152–161.
21. Garg, S., Dada, T., Talwar, D., Biswas, N. (1997) Endogenous cortisol profile in patients with central serous chorioretinopathy, British Journal of Ophthalmology, 81: pp. 962-964.
22. Haimovici, R., Koh, S., Gagnon, D., Lehrfeld, T., Wellik, S. (2004) Risk factors for central serous chorioretinopathy: A case–control study. Ophthalmology, 111: pp. 244-249.
23. Mohseni, M., Blair, K., Gurnani, B., et al (2024) Blunt Eye Trauma. StatPearls Publishing, Available from: https://www.ncbi.nlm.nih.gov/books/NBK470379/
24. Steeples, L., Sharma, V., & Mercieca, K. (2015). Traumatic central serous chorioretinopathy. Indian Journal of Ophthalmology, 63, pp. 536-538.
25. Ponce, C. M. P., Mohidat, H. M., & Garcia, C. A. (2012). Central serous chorioretinopathy after blunt trauma. BMJ Case Reports, 2012.
26. Jackson, T. E., Sood, V., & Haigh, P. M. (2012). Central serous chorioretinopathy secondary to trauma. Oman Journal of Ophthalmology, 5, pp. 51-52.
27. Gelber GS, Schatz H. (1987) Loss of vision due to central serous chorioretinopathy following psychological stress. American Journal of Psychiatry, 144: pp. 46–50.
28. Tatham A, Macfarlane A. (2006) The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT, Journal of Ocular Pharmacology and Therapeutics, 22: pp. 145–149.
29. Spahn C, Wiek J, Burger T. (2004) Operationalized psycho-dynamic diagnostics (OPD) in patients with central serous chorioretinopathy, Psychotherapie Psychosomatik, medizinische Psychologie, 54: pp. 52–57.
30. Jinghua, S., Junfeng, T., Zhitao, W., et al (2003) Effect of catecholamine on central serous chorioretinopathy, Current Medical Science, 23: pp. 313–316.
31. Haimovici, R., Rumelt, S., Melby, J., (2003) Endocrine abnormalities in patients with central serous chorioretinopathy, Ophthalmology, 110: pp. 698–703.
32. Bouzas, E., Scott, M., Mastorakos, G., et al (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol, 111: pp. 1229–1233.
33. Jonas, J., Kamppeter, B. (2005) Intravitreal triamcinolone acetonide and central serous chorioretinopathy. British Journal of Ophthalmology, 89: pp. 386–387.
34. Lee, C., Kang, E., Lee, K., et al. (2011) Central serous chorioretinopathy after renal transplantation. Retina, 31: pp. 1896–1903.
35. Liegl, R., & Ulbig, M. W. (2014). Central serous chorioretinopathy, Ophthalmologica, 232: pp. 65-76.
36. Gemenetzi, M., De Salvo, G., and Lotery, A. (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (London), 24: pp. 1743 – 1756.
37. Lim, J., Kim, M. (2011) The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefe’s Archive for Clininical Experimental Ophthalmology, 249: pp.969 – 974.